Adenoviral pneumonia
ICD-10 A79.0 is a billable code used to indicate a diagnosis of adenoviral pneumonia.
Adenoviral pneumonia is a respiratory infection caused by adenoviruses, which are a group of viruses that can lead to a variety of illnesses, including respiratory infections, conjunctivitis, and gastroenteritis. This condition is characterized by inflammation of the lung tissue, leading to symptoms such as cough, fever, difficulty breathing, and chest pain. Adenoviral pneumonia is particularly prevalent in children and can occur in outbreaks, especially in crowded settings such as schools and daycare centers. The diagnosis is typically confirmed through clinical evaluation and laboratory tests, including PCR assays or viral cultures. Treatment primarily focuses on supportive care, as there are no specific antiviral therapies for adenoviral infections. Patients with underlying health conditions or weakened immune systems may experience more severe symptoms and complications. Understanding the epidemiology and transmission routes of adenoviruses is crucial, especially in the context of travel-related infections, where exposure to contaminated environments can increase the risk of infection.
Detailed clinical notes including travel history, symptom onset, and laboratory results.
Patients presenting with respiratory symptoms after travel to endemic areas.
Consideration of co-infections and the patient's immunocompromised status.
Thorough documentation of symptoms, exposure history, and vaccination status.
Children presenting with fever and respiratory distress in a daycare setting.
Monitoring for complications in young children and those with underlying health issues.
Used when laboratory confirmation of adenoviral infection is performed.
Documentation of the clinical indication for testing and results.
Infectious disease specialists may order this test more frequently.
Common symptoms include cough, fever, difficulty breathing, and chest pain. Symptoms can vary based on the patient's age and health status.
Diagnosis is typically made through clinical evaluation and confirmed with laboratory tests such as PCR or viral cultures.
Treatment is primarily supportive, focusing on symptom management, as there are no specific antiviral treatments for adenoviral infections.
Yes, particularly in individuals with weakened immune systems or underlying respiratory conditions, complications can include severe respiratory distress and secondary infections.
